… by one cycle twice per month and then tapered depending on clinical response. For aGVHD
the recommended schedule is two or three sessions per week until complete response [8]. …

… host disease (cGvHD) following treatment with extracorporeal photopheresis (… response.
Chronic GvHD activity fluctuates over time, so we retrospectively evaluated cGvHD responses in …

… complete response (CR) to extracorporeal photopheresis (ECP) compared with those with
no CR. This figure was published in Haematologica, Volume 91: Greinix et al, The effect of …

… status of the ‘one-step’, closed photopheresis systems and the various cell separation and
drug photo activation systems used in the ‘two step’ photopheresis … skin overall response rate …

… approval status of ‘one-step’ closed photopheresis … Extracorporeal photopheresis is an
attractive treatment option exerting glucocorticosteroid-sparing effects and showing response …

… In contrast to the study by Perotti and colleagues,45 which showed no association between
the grade of aGVHD and the response, in our series, we found a high response rate in …

… with SR aGVHD, comparing extracorporeal photopheresis (ECP; n = … Response was assessed
at 4 weeks after anticytokine therapy or … Given the variability of response assessment and …

… Extracorporeal photopheresis can be safely used in acute GvHD as adjuvant, as well as
second-line therapy. Treatment 2–3 x weekly is recommended until a response to … joint status at …

… Our aim was to evaluate extracorporeal photopheresis (ECP) treatment in cGVHD patients
with different organ involvement to detect subgroups of patients with the best response. …

… extracorporeal photopheresis as the sole therapy for up to 1 year. The cohort showed a
significant reduction of skin scores during treatment (P = .001). Thirteen patients (57%) achieved …